[ad_1]
In the first phase of the epidemic, we tried to figure out how long it would take for the first vaccine to appear, and then I carelessly said that it was expected in November. I have to say it wasn’t so, too bad
– Professor Béla Merkely said in an interview with Origó. The rector of Semmelweis University added:
that testing of the first vaccines, the triple phase trials, will almost certainly be completed in November.
He is also sure that vaccination in Europe could start as early as December, but that will require many hundreds of millions of vaccines. He said it would be appropriate to first vaccinate those who care for coronavirus patients.
It also revealed that 26 patients received the new Hungarian-made remdesivir and that all are alive, which is a “very serious” result. No side effects were found and the first patient was now able to go home.
He said a patient named remdesivir should not be expected to develop bilateral pneumonia because then only a ventilator can be used to improve the patient’s condition. Béla Merkely sees
therapy should be started as soon as the patient’s condition begins to deteriorate.
He added that remdesivir is the most effective antiviral drug available today to treat those infected with the new type of coronavirus, and it is expected to be available soon in five more institutions where coronavirus patients are cared for. He noted that there are criteria for who should be treated with such drug therapy.
[ad_2]
